![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 23
Zeitschriftenartikel
Ma, Tianshu; An, Yidan; Li, Sheng; Zhao, Yue; Wang, Huayang; Wang, Changlei; Maier, Stefan A. und Li, Xiaofeng
(2022):
Low Band Gap Perovskite Concentrator Solar Cells: Physics, Device Simulation, and Experiment.
In: ACS Applied Materials & Interfaces, Bd. 14, Nr. 26: S. 29856-29866
Zhao, Yue; Wei, Kongyuan; Chi, Hao; Xia, Zhijia und Li, Xiaosong
(2022):
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
In: Frontiers in Immunology, Bd. 13, 1022808
Chi, Hao; Jiang, Puyu; Xu, Ke; Zhao, Yue; Song, Bingyu; Peng, Gaoge; He, Bingsheng; Liu, Xin; Xia, Zhijia und Tian, Gang
(2022):
A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration.
In: Frontiers in Genetics, Bd. 13, 984273
Wang, Xiaojing; Zhao, Yue; Strohmer, Dorothee Franziska; Yang, Wenjin; Xia, Zhijia und Yu, Cong
(2022):
The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma.
In: Frontiers in Genetics, Bd. 13, 983672
Soltani, Mojdeh; Zhao, Yue; Xia, Zhijia; Ganjalikhani Hakemi, Mazdak und Bazhin, Alexandr V.
(10. November 2021):
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies.
In: Frontiers in Oncology, Bd. 11, 767026
[PDF, 1MB]
Zhao, Yue; Baldin, Alexey V.; Isayev, Orkhan; Werner, Jens; Zamyatnin, Andrey A. und Bazhin, Alexandr
(2021):
Cancer Vaccines: Antigen Selection Strategy.
In: Vaccines, Bd. 9, Nr. 2, 85
Sun, Jialei; Zhou, Chenhao; Zhao, Yue; Zhang, Xiaofei; Chen, Wanyong; Zhou, Qiang; Hu, Bo; Gao, Dongmei; Raatz, Lisa; Wang, Zhefang; Nelson, Peter J.; Jiang, Yuchao; Ren, Ning; Bruns, Christiane J. und Zhou, Haijun
(2021):
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
In: Redox Biology, Bd. 41, 101942
Fu, Yan; Zou, Tiantian; Shen, Xiaotian; Nelson, Peter J.; Li, Jiahui; Wu, Chao; Yang, Jimeng; Zheng, Yan; Bruns, Christiane; Zhao, Yue; Qin, Lunxiu und Dong, Qiongzhu
(2021):
Lipid metabolism in cancer progression and therapeutic strategies.
In: Medcomm, Bd. 2, Nr. 1: S. 27-59
Bidram, Maryam; Zhao, Yue; Shebardina, Natalia G.; Baldin, Alexey V.; Bazhin, Alexandr V.; Ganjalikhany, Mohamad Reza; Zamyatnin, Andrey A. und Ganjalikhani-hakemi, Mazdak
(2021):
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients.
In: Vaccines, Bd. 9, Nr. 10, 1060
Mahajan, Ujjwal M.; Goni, Elisabetta; Langhoff, Enno; Li, Qi; Costello, Eithne; Greenhalf, William; Kruger, Stephan; Ormanns, Steffen; Halloran, Christopher; Ganeh, Paula; Marron, Manuela; Laemmerhirt, Felix; Zhao, Yue; Beyer, Georg; Weiss, Frank-Ulrich; Sendler, Matthias; Bruns, Christiane J.; Kohlmann, Thomas; Kirchner, Thomas; Werner, Jens; D'Haese, Jan G.; Bergwelt, Michael von; Heinemann, Volker; Neoptolemos, John P.; Buechler, Markus W.; Belka, Claus; Boeck, Stefan; Lerch, Markus M. und Mayerle, Julia
(2020):
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.
In: Jnci Cancer Spectrum, Bd. 4, Nr. 1, pkz060
Zhao, Yue; Li, Jiahui; Li, Dai; Wang, Zhefang; Zhao, Jiangang; Wu, Xiaolin; Sun, Qiye; Lin, Peter Ping; Plum, Patrick; Damanakis, Alexander; Gebauer, Florian; Zhou, Menglong; Zhang, Zhen; Schloesser, Hans; Jauch, Karl-Walter; Nelson, Peter J. und Bruns, Christiane J.
(2020):
Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.
In: Seminars in Cancer Biology, Bd. 60: S. 334-343
Wang, Zhefang; Qin, Jie; Zhao, Jiangang; Li, Jiahui; Li, Dai; Popp, Marie; Popp, Felix; Alakus, Hakan; Kong, Bo; Dong, Qiongzhu; Nelson, Peter J.; Zhao, Yue und Bruns, Christiane J.
(2020):
Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer.
In: Theranostics, Bd. 10, Nr. 16: S. 7178-7192
Zheng, Yan; Wu, Chao; Yang, Jimeng; Zhao, Yue; Jia, Huliang; Xue, Min; Xu, Da; Yang, Feng; Fu, Deliang; Wang, Chaoqun; Hu, Beiyuan; Zhang, Ze; Li, Tianen; Yan, Shican; Wang, Xuan; Nelson, Peter J.; Bruns, Christiane; Qin, Lunxiu und Dong, Qiongzhu
(2020):
Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
In: Signal Transduction and Targeted Therapy, Bd. 5, Nr. 1, 53
Zhao, Jiangang; Schlosser, Hans A.; Wang, Zhefang; Qin, Jie; Li, Jiahui; Popp, Felix; Popp, Marie Christine; Alakus, Hakan; Chon, Seung-Hun; Hansen, Hinrich P.; Neiss, Wolfram E.; Jauch, Karl-Walter; Bruns, Christiane J. und Zhao, Yue
(2019):
Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer.
In: Cancers, Bd. 11, Nr. 6, 874
Pozios, Ioannis; Knoesel, Thomas; Zhao, Yue; Assmann, Gerald; Pozios, Iraklis; Müller, Mario H.; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2018):
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 10: S. 1887-1897
Seeliger, Hendrik; Pozios, Ioannis; Assmann, Gerald; Zhao, Yue; Müller, Mario H.; Knoesel, Thomas; Kreis, Martin E. und Bruns, Christiane J.
(2018):
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.
In: BMC Cancer
18:1049
[PDF, 1MB]
Zhao, Yue; Dong, Qiongzhu; Li, Jiahui; Zhang, Kaili; Qin, Jie; Zhao, Jiangang; Sun, Qiye; Wang, Zhefang; Wartmann, Thomas; Jauch, Karl Walter; Nelson, Peter J.; Qin, LunXiu und Bruns, Christiane
(2018):
Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
In: Seminars in Cancer Biology, Bd. 53: S. 139-155
Zhao, Yue; Altendorf-Hofmann, Annelore; Pozios, Ioannis; Camaj, Peter; Däberitz, Therese; Wang, Xiaoyan; Niess, Hanno; Seeliger, Hendrik; Popp, Felix; Betzler, Christopher; Settmacher, Utz; Jauch, Karl-Walter; Bruns, Christiane und Knösel, Thomas
(2017):
Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 6: S. 1061-1068
Klein, Brianna J.; Wang, Xiaoyan; Cui, Gaofeng; Yuan, Chao; Botuyan, Maria Victoria; Lin, Kevin; Lu, Yue; Wang, Xiaolu; Zhao, Yue; Bruns, Christiane J.; Mer, Georges; Shi, Xiaobing und Kutateladze, Tatiana G.
(2016):
PHF20 Readers Link Methylation of Histone H3K4 and p53 with H4K16 Acetylation.
In: Cell Reports, Bd. 17, Nr. 4: S. 1158-1170
[PDF, 10MB]
Zhao, Lu; Zhao, Yue; Schwarz, Bettina; Mysliwietz, Josef; Hartig, Roland; Camaj, Peter; Bao, Qi; Jauch, Karl-Walter; Guba, Makus; Ellwart, Joachim Walter; Nelson, Peter Jon und Bruns, Christiane Josephine
(2016):
Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.
In: International Journal of Oncology, Bd. 49, Nr. 1: S. 99-110
Hagenhoff, Anna; Bruns, Christiane J.; Zhao, Yue; Lüttichau, Irene von; Niess, Hanno; Spitzweg, Christine und Nelson, Peter J.
(2016):
Harnessing mesenchymal stem cell homing as an anticancer therapy.
In: Expert Opinion On Biological therapy, Bd. 16, Nr. 9: S. 1079-1092
Wang, Yan; Zhao, Yue; Herbst, Andreas; Kalinski, Thomas; Qin, Jiwei; Wang, Xiaoyan; Jiang, Zhenzhong; Benedix, Frank; Franke, Sabine; Wartman, Thomas; Camaj, Peter; Halangk, Walter; Kolligs, FrankT.; Jauch, Karl W.; Nelson, Peter J. und Bruns, Christiane J.
(2016):
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
In: Annals of Surgery, Bd. 264, Nr. 5: S. 804-814
[PDF, 1MB]
Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J. und Modest, Dominik P.
(2015):
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
In: Anti-Cancer Drugs, Bd. 26, Nr. 4: S. 371-378
[PDF, 251kB]